(16α)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione
|
|
- CAS-Nr.
- 216453-74-6
- Englisch Name:
- (16α)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione
- Synonyma:
- 11-Keto Budesonide;Budesonide-11-keto;Budesonide EP Imp L;Budesonide iMpurit L;Budesonide EP Impurity L;Budesonide USP Related Compound L;Budesonide EP Impurity L (Mixture of Epimer);11-Keto Budesonide
(Mixture of DiastereoMers);Budesonide Impurity L(Mixture of Diastereomers);Budesonide Impurity 12(Budesonide EP Impurity L)
- CBNumber:
- CB92622193
- Summenformel:
- C25H32O6
- Molgewicht:
- 428.52
- MOL-Datei:
- 216453-74-6.mol
|
(16α)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione Eigenschaften
- Schmelzpunkt:
- >97°C (dec.)
- Siedepunkt:
- 601.7±55.0 °C(Predicted)
- Dichte
- 1.27±0.1 g/cm3(Predicted)
- storage temp.
- -20°C Freezer, Under inert atmosphere
- L?slichkeit
- Chloroform (Slightly), Dichloromethane (Slightly), Methanol (Slightly)
- pka
- 12.83±0.10(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White to Light Yellow
Sicherheit
(16α)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
11-Keto Budesonide is an impurity of Budesonide (B689490), an antiinflammatory agent.
(16α)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(16α)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 69)Lieferanten
216453-74-6()Verwandte Suche:
- 11-Keto Budesonide
- Budesonide IMpurity L (11-Keto Budesonide, Mixture of DiastereoMers)
- 11-Keto Budesonide
(Mixture of DiastereoMers)
- 16α,17-[(1RS)-butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione
- Budesonide EP Impurity L
- Budesonide Impurity 12(Budesonide EP Impurity L)
- Budesonide EP Impurity L (11-Keto Budesonide) (Mixture of Diastereomers)
- Budesonide iMpurit L
- Budesonide EP Imp L
- Budesonide Impurity 7/Budesonide EP Impurity L/11-Keto Budesonide(Mixture of Diastereomers)
- Budesonide Impurity L(Mixture of Diastereomers)
- Pregna-1,4-diene-3,11,20-trione, 16,17-[butylidenebis(oxy)]-21-hydroxy-, (16α)-
- (6aR,6bS,8aS,8bS,11aR,12aS,12bS)-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6b,8,8a,8b,11a,12,12a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxole-4,7(2H,6aH)-dione
- Budesonide EP Impurity-L/ Budesonide Related Compund L(11-Keto Budesonide)
- (6aR,6bS,8aS,8bS,11aR,12aS,12bS)-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,6a,6b,8,8a,8b,11a,12,12a,12b-decahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxole-4,7(2H)-dione
- 11-Keto BudesonideQ: What is
11-Keto Budesonide Q: What is the CAS Number of
11-Keto Budesonide Q: What is the storage condition of
11-Keto Budesonide Q: What are the applications of
11-Keto Budesonide
- 16α,17-[(1RS)-Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione
- Budesonide Related Compound L (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-t (1078289)
- Budesonide USP Related Compound L
- (6aR,6bS,8aS,8bS,11aR,12aS,12bS)-8b-(2-Hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6b,8,8a,8b,11a,12,12a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxole-4,7(2H,6aH)-dione (Budesonide Impurity)
- Budesonide EP Impurity L (Mixture of Diastereomers)
- Budesonide-11-keto
- (16α)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione
- (6aR,6bS,8aS,8bS,11aR,12aS,12bS)-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,6a,6b,8,8a,8b,11a,12,12a,12b-decahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxole-4,7(2H)-dione
- (6aR,6bS,8aS,8bS,11aR,12aS,12bS)-8b-(2-Hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6b,8,8a,8b,11a,12,12a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxole-4,7(2H,6aH)-dione (Budesonide Impurity)
- Budesonide EP Impurity L (Mixture of Epimer)
- Budesonide EP Impurity L (Budesonide USP Related Compound L, 11-Keto Budesonide) (Mixture of Diastereomers)
- 216453-74-6
- Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, Steroids